In PD model mice, 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) has been shown to induce depression‐like behavior, and this is accompanied by an increase in the expression levels of STING and IRF3 in the hippocampus. Here, IRF3 is linked to depressive disorder.